"this means that for the first time, an injectionfree regimen will be recommended for all patients with rifampicin resistant tuberculosis in south africa.

le mithetho iyilwayo inga maqalela amalinge okulu ngiselela ukuba abantu abaninzi bafumane iinkonzo zonyango ngenhi.
